Clinical trials
Phase 3 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
642 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 318 |
| 2021 | 175 |
| 2022 | 77 |
| 2023 | 38 |
| 2024 | 14 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 301 |
| Unknown status | 157 |
| Terminated | 93 |
| Withdrawn | 58 |
| Recruiting | 15 |
| Active, not recruiting | 9 |
| Suspended | 7 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 16 |
| Assistance Publique - Hôpitaux de Paris | 13 |
| BioNTech SE | 11 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 8 |
| Novavax | 8 |
| Susanna Naggie, MD | 8 |
| Ain Shams University | 6 |
| AstraZeneca | 6 |
| Gilead Sciences | 6 |
| ModernaTX, Inc. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 642 |
| Coronavirus Infections | 102 |
| Severe Acute Respiratory Syndrome | 52 |
| Pneumonia | 32 |
| Respiratory Distress Syndrome | 22 |
| Virus Diseases | 22 |
| Pneumonia, Viral | 16 |
| Coronaviridae Infections | 15 |
| RNA Virus Infections | 15 |
| Nidovirales Infections | 13 |
Trials
Showing 1 to 25 of 642. Each trial links to its page on Pharma Observatory.
542 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.